These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 6032217)
21. [Oral anticoagulation with vitamin K antagonists]. Alberio L Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470 [TBL] [Abstract][Full Text] [Related]
22. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH Thromb Haemost; 2004 Jul; 92(1):61-6. PubMed ID: 15213846 [TBL] [Abstract][Full Text] [Related]
23. [Coumarin-induced retroperitoneal hematoma: 2 case reports]. Rodríguez Cuartero A; Urbano Jiménez F An Med Interna; 2000 Jan; 17(1):49. PubMed ID: 10730409 [No Abstract] [Full Text] [Related]
24. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon. Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752 [TBL] [Abstract][Full Text] [Related]
25. [Interaction between melilot and acenocoumarol? (Melilotruscus aculeatus)]. Chiffoleau A; Huguenin H; Veyrac G; Argaiz V; Dupe D; Kayser M; Bourin M; Jolliet P Therapie; 2001; 56(3):321-2. PubMed ID: 11475815 [No Abstract] [Full Text] [Related]
26. The effect of acenocoumarol on the antiplatelet effect of clopidogrel. Dewilde WJ; Janssen PW; Bergmeijer TO; Kelder JC; Hackeng CM; ten Berg JM Thromb Haemost; 2015 Oct; 114(4):708-16. PubMed ID: 26177793 [TBL] [Abstract][Full Text] [Related]
27. Possible coumarin hepatotoxicity. Beinssen AP Med J Aust; 1994 Dec 5-19; 161(11-12):725. PubMed ID: 7794322 [No Abstract] [Full Text] [Related]
28. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives. Gärtner BC; Seifert CB; Michalk DV; Roth B Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045 [TBL] [Abstract][Full Text] [Related]
29. [Coumarin necrosis. A rare severe complication of oral anticoagulation]. Brunner W; Kuhn M; Hartmann G Schweiz Rundsch Med Prax; 1985 Feb; 74(7):141-3. PubMed ID: 3975527 [No Abstract] [Full Text] [Related]
30. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979 [TBL] [Abstract][Full Text] [Related]
31. [Capillary damage and prothrombin complex following coumarin therapy. Observations on an unusual marcumar poisoning]. Gross R; Schrank W Med Welt; 1965 Jul; 28():1543-7. PubMed ID: 5838795 [No Abstract] [Full Text] [Related]
32. Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity. Nahar R; Dube D; Parakh R; Deb R; Saxena R; Singh TP; Verma IC Thromb Res; 2013 Jun; 131(6):535-9. PubMed ID: 23582453 [TBL] [Abstract][Full Text] [Related]
33. Increased INR after gefitinib and acenocoumarol co-administration. Ribed A; Escudero-Vilaplana V; Gonzalez-Haba E; Sanjurjo M Eur Rev Med Pharmacol Sci; 2014; 18(12):1720-2. PubMed ID: 24992614 [TBL] [Abstract][Full Text] [Related]